nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—Losartan—coronary artery disease	0.229	1	CrCtD
Eprosartan—Angiotensin 2 Receptor Antagonists—Telmisartan—coronary artery disease	0.122	0.37	CiPCiCtD
Eprosartan—Angiotensin 2 Receptor Antagonists—Losartan—coronary artery disease	0.104	0.315	CiPCiCtD
Eprosartan—Angiotensin 2 Receptor Antagonists—Valsartan—coronary artery disease	0.104	0.315	CiPCiCtD
Eprosartan—AGTR1—coronary artery disease	0.0892	1	CbGaD
Eprosartan—Losartan—Telmisartan—coronary artery disease	0.0511	0.382	CrCrCtD
Eprosartan—Losartan—Olmesartan—coronary artery disease	0.0423	0.316	CrCrCtD
Eprosartan—Losartan—Valsartan—coronary artery disease	0.0404	0.302	CrCrCtD
Eprosartan—AGTR1—Olmesartan—coronary artery disease	0.0308	0.198	CbGbCtD
Eprosartan—AGTR1—Telmisartan—coronary artery disease	0.0247	0.158	CbGbCtD
Eprosartan—AGTR1—Valsartan—coronary artery disease	0.024	0.154	CbGbCtD
Eprosartan—AGTR1—Losartan—coronary artery disease	0.0138	0.0883	CbGbCtD
Eprosartan—ABCC2—Olmesartan—coronary artery disease	0.00727	0.0466	CbGbCtD
Eprosartan—ABCC2—Telmisartan—coronary artery disease	0.00581	0.0372	CbGbCtD
Eprosartan—ABCC2—Pitavastatin—coronary artery disease	0.00581	0.0372	CbGbCtD
Eprosartan—ABCC2—Ezetimibe—coronary artery disease	0.00428	0.0275	CbGbCtD
Eprosartan—ABCC2—Simvastatin—coronary artery disease	0.00398	0.0255	CbGbCtD
Eprosartan—ABCC2—Lovastatin—coronary artery disease	0.0039	0.025	CbGbCtD
Eprosartan—ABCC2—Pravastatin—coronary artery disease	0.0039	0.025	CbGbCtD
Eprosartan—ABCC2—Atorvastatin—coronary artery disease	0.00355	0.0227	CbGbCtD
Eprosartan—ABCC2—Furosemide—coronary artery disease	0.00331	0.0212	CbGbCtD
Eprosartan—CYP2C9—Fenofibrate—coronary artery disease	0.00322	0.0206	CbGbCtD
Eprosartan—CYP2C9—Gemfibrozil—coronary artery disease	0.00258	0.0165	CbGbCtD
Eprosartan—CYP2C9—Clopidogrel—coronary artery disease	0.00223	0.0143	CbGbCtD
Eprosartan—CYP2C9—cardial valve—coronary artery disease	0.00206	0.395	CbGeAlD
Eprosartan—CYP2C9—Pitavastatin—coronary artery disease	0.00195	0.0125	CbGbCtD
Eprosartan—CYP2C9—Valsartan—coronary artery disease	0.0019	0.0122	CbGbCtD
Eprosartan—CYP2C9—Rosuvastatin—coronary artery disease	0.00144	0.00922	CbGbCtD
Eprosartan—CYP2C9—Acetylsalicylic acid—coronary artery disease	0.0014	0.00899	CbGbCtD
Eprosartan—CYP2C9—Simvastatin—coronary artery disease	0.00134	0.00857	CbGbCtD
Eprosartan—CYP2C9—Pravastatin—coronary artery disease	0.00131	0.00839	CbGbCtD
Eprosartan—CYP2C9—Lovastatin—coronary artery disease	0.00131	0.00839	CbGbCtD
Eprosartan—CYP2C9—Atorvastatin—coronary artery disease	0.00119	0.00764	CbGbCtD
Eprosartan—CYP2C9—Losartan—coronary artery disease	0.00109	0.00699	CbGbCtD
Eprosartan—AGTR1—artery—coronary artery disease	0.000642	0.123	CbGeAlD
Eprosartan—AGTR1—endothelium—coronary artery disease	0.000543	0.104	CbGeAlD
Eprosartan—AGTR1—cardiac ventricle—coronary artery disease	0.00036	0.0691	CbGeAlD
Eprosartan—AGTR1—myocardium—coronary artery disease	0.000339	0.065	CbGeAlD
Eprosartan—AGTR1—heart—coronary artery disease	0.000237	0.0453	CbGeAlD
Eprosartan—AGTR1—cardiovascular system—coronary artery disease	0.000223	0.0428	CbGeAlD
Eprosartan—Losartan—AGTR1—coronary artery disease	0.000203	0.446	CrCbGaD
Eprosartan—AGTR1—cardiac atrium—coronary artery disease	0.000202	0.0388	CbGeAlD
Eprosartan—AGTR1—blood—coronary artery disease	0.000177	0.0338	CbGeAlD
Eprosartan—ABCC2—blood—coronary artery disease	0.000128	0.0245	CbGeAlD
Eprosartan—Losartan—ACE—coronary artery disease	0.000117	0.258	CrCbGaD
Eprosartan—CYP2C9—heart—coronary artery disease	0.000114	0.0218	CbGeAlD
Eprosartan—CYP2C9—cardiovascular system—coronary artery disease	0.000107	0.0206	CbGeAlD
Eprosartan—Losartan—CYP2C19—coronary artery disease	8.66e-05	0.19	CrCbGaD
Eprosartan—CYP2C9—blood—coronary artery disease	8.5e-05	0.0163	CbGeAlD
Eprosartan—Losartan—ALB—coronary artery disease	4.8e-05	0.106	CrCbGaD
Eprosartan—Dry mouth—Ramipril—coronary artery disease	1.27e-05	0.000304	CcSEcCtD
Eprosartan—Chest pain—Timolol—coronary artery disease	1.27e-05	0.000304	CcSEcCtD
Eprosartan—Myalgia—Timolol—coronary artery disease	1.27e-05	0.000304	CcSEcCtD
Eprosartan—Arthralgia—Timolol—coronary artery disease	1.27e-05	0.000304	CcSEcCtD
Eprosartan—Vomiting—Ezetimibe—coronary artery disease	1.27e-05	0.000304	CcSEcCtD
Eprosartan—Hypersensitivity—Pravastatin—coronary artery disease	1.26e-05	0.000303	CcSEcCtD
Eprosartan—Gastrointestinal pain—Perindopril—coronary artery disease	1.26e-05	0.000303	CcSEcCtD
Eprosartan—Anxiety—Timolol—coronary artery disease	1.26e-05	0.000303	CcSEcCtD
Eprosartan—Angioedema—Lisinopril—coronary artery disease	1.26e-05	0.000303	CcSEcCtD
Eprosartan—Pruritus—Olmesartan—coronary artery disease	1.26e-05	0.000303	CcSEcCtD
Eprosartan—Decreased appetite—Losartan—coronary artery disease	1.26e-05	0.000302	CcSEcCtD
Eprosartan—Body temperature increased—Captopril—coronary artery disease	1.26e-05	0.000302	CcSEcCtD
Eprosartan—Abdominal pain—Captopril—coronary artery disease	1.26e-05	0.000302	CcSEcCtD
Eprosartan—Dizziness—Simvastatin—coronary artery disease	1.25e-05	0.000301	CcSEcCtD
Eprosartan—Rash—Ezetimibe—coronary artery disease	1.25e-05	0.000301	CcSEcCtD
Eprosartan—Dermatitis—Ezetimibe—coronary artery disease	1.25e-05	0.000301	CcSEcCtD
Eprosartan—Discomfort—Timolol—coronary artery disease	1.25e-05	0.000301	CcSEcCtD
Eprosartan—Asthenia—Niacin—coronary artery disease	1.25e-05	0.0003	CcSEcCtD
Eprosartan—Fatigue—Losartan—coronary artery disease	1.25e-05	0.0003	CcSEcCtD
Eprosartan—Headache—Ezetimibe—coronary artery disease	1.25e-05	0.000299	CcSEcCtD
Eprosartan—Malaise—Lisinopril—coronary artery disease	1.25e-05	0.000299	CcSEcCtD
Eprosartan—Vertigo—Lisinopril—coronary artery disease	1.24e-05	0.000298	CcSEcCtD
Eprosartan—Dry mouth—Timolol—coronary artery disease	1.24e-05	0.000298	CcSEcCtD
Eprosartan—Pain—Losartan—coronary artery disease	1.24e-05	0.000298	CcSEcCtD
Eprosartan—Constipation—Losartan—coronary artery disease	1.24e-05	0.000298	CcSEcCtD
Eprosartan—Syncope—Lisinopril—coronary artery disease	1.24e-05	0.000297	CcSEcCtD
Eprosartan—Vomiting—Eplerenone—coronary artery disease	1.24e-05	0.000297	CcSEcCtD
Eprosartan—Feeling abnormal—Furosemide—coronary artery disease	1.24e-05	0.000297	CcSEcCtD
Eprosartan—Nausea—Fenofibrate—coronary artery disease	1.23e-05	0.000296	CcSEcCtD
Eprosartan—Pruritus—Niacin—coronary artery disease	1.23e-05	0.000296	CcSEcCtD
Eprosartan—Asthenia—Pravastatin—coronary artery disease	1.23e-05	0.000296	CcSEcCtD
Eprosartan—Gastrointestinal pain—Furosemide—coronary artery disease	1.23e-05	0.000295	CcSEcCtD
Eprosartan—Rash—Eplerenone—coronary artery disease	1.23e-05	0.000295	CcSEcCtD
Eprosartan—Urticaria—Perindopril—coronary artery disease	1.23e-05	0.000295	CcSEcCtD
Eprosartan—Hypersensitivity—Trandolapril—coronary artery disease	1.23e-05	0.000295	CcSEcCtD
Eprosartan—Dermatitis—Eplerenone—coronary artery disease	1.23e-05	0.000295	CcSEcCtD
Eprosartan—Diarrhoea—Valsartan—coronary artery disease	1.23e-05	0.000294	CcSEcCtD
Eprosartan—Shock—Ramipril—coronary artery disease	1.22e-05	0.000294	CcSEcCtD
Eprosartan—Hypersensitivity—Enalapril—coronary artery disease	1.22e-05	0.000293	CcSEcCtD
Eprosartan—Abdominal pain—Perindopril—coronary artery disease	1.22e-05	0.000293	CcSEcCtD
Eprosartan—Body temperature increased—Perindopril—coronary artery disease	1.22e-05	0.000293	CcSEcCtD
Eprosartan—Palpitations—Lisinopril—coronary artery disease	1.22e-05	0.000293	CcSEcCtD
Eprosartan—Diarrhoea—Olmesartan—coronary artery disease	1.22e-05	0.000293	CcSEcCtD
Eprosartan—Headache—Eplerenone—coronary artery disease	1.22e-05	0.000293	CcSEcCtD
Eprosartan—Thrombocytopenia—Ramipril—coronary artery disease	1.22e-05	0.000292	CcSEcCtD
Eprosartan—Pruritus—Pravastatin—coronary artery disease	1.21e-05	0.000291	CcSEcCtD
Eprosartan—Loss of consciousness—Lisinopril—coronary artery disease	1.21e-05	0.000291	CcSEcCtD
Eprosartan—Nausea—Clopidogrel—coronary artery disease	1.21e-05	0.000291	CcSEcCtD
Eprosartan—Tachycardia—Ramipril—coronary artery disease	1.21e-05	0.000291	CcSEcCtD
Eprosartan—Vomiting—Simvastatin—coronary artery disease	1.21e-05	0.00029	CcSEcCtD
Eprosartan—Hypersensitivity—Telmisartan—coronary artery disease	1.21e-05	0.000289	CcSEcCtD
Eprosartan—Cough—Lisinopril—coronary artery disease	1.21e-05	0.000289	CcSEcCtD
Eprosartan—Nausea—Lovastatin—coronary artery disease	1.21e-05	0.000289	CcSEcCtD
Eprosartan—Hyperhidrosis—Ramipril—coronary artery disease	1.2e-05	0.000288	CcSEcCtD
Eprosartan—Rash—Simvastatin—coronary artery disease	1.2e-05	0.000287	CcSEcCtD
Eprosartan—Dermatitis—Simvastatin—coronary artery disease	1.2e-05	0.000287	CcSEcCtD
Eprosartan—Asthenia—Trandolapril—coronary artery disease	1.2e-05	0.000287	CcSEcCtD
Eprosartan—Shock—Timolol—coronary artery disease	1.2e-05	0.000287	CcSEcCtD
Eprosartan—Feeling abnormal—Losartan—coronary artery disease	1.19e-05	0.000287	CcSEcCtD
Eprosartan—Urticaria—Furosemide—coronary artery disease	1.19e-05	0.000286	CcSEcCtD
Eprosartan—Diarrhoea—Niacin—coronary artery disease	1.19e-05	0.000286	CcSEcCtD
Eprosartan—Asthenia—Enalapril—coronary artery disease	1.19e-05	0.000286	CcSEcCtD
Eprosartan—Headache—Simvastatin—coronary artery disease	1.19e-05	0.000285	CcSEcCtD
Eprosartan—Abdominal pain—Furosemide—coronary artery disease	1.19e-05	0.000285	CcSEcCtD
Eprosartan—Body temperature increased—Furosemide—coronary artery disease	1.19e-05	0.000285	CcSEcCtD
Eprosartan—Gastrointestinal pain—Losartan—coronary artery disease	1.19e-05	0.000285	CcSEcCtD
Eprosartan—Dizziness—Valsartan—coronary artery disease	1.19e-05	0.000284	CcSEcCtD
Eprosartan—Anorexia—Ramipril—coronary artery disease	1.18e-05	0.000284	CcSEcCtD
Eprosartan—Nausea—Ezetimibe—coronary artery disease	1.18e-05	0.000284	CcSEcCtD
Eprosartan—Dizziness—Olmesartan—coronary artery disease	1.18e-05	0.000283	CcSEcCtD
Eprosartan—Pruritus—Trandolapril—coronary artery disease	1.18e-05	0.000283	CcSEcCtD
Eprosartan—Chest pain—Lisinopril—coronary artery disease	1.18e-05	0.000282	CcSEcCtD
Eprosartan—Arthralgia—Lisinopril—coronary artery disease	1.18e-05	0.000282	CcSEcCtD
Eprosartan—Myalgia—Lisinopril—coronary artery disease	1.18e-05	0.000282	CcSEcCtD
Eprosartan—Hyperhidrosis—Timolol—coronary artery disease	1.17e-05	0.000282	CcSEcCtD
Eprosartan—Asthenia—Telmisartan—coronary artery disease	1.17e-05	0.000282	CcSEcCtD
Eprosartan—Pruritus—Enalapril—coronary artery disease	1.17e-05	0.000282	CcSEcCtD
Eprosartan—Diarrhoea—Pravastatin—coronary artery disease	1.17e-05	0.000282	CcSEcCtD
Eprosartan—Anxiety—Lisinopril—coronary artery disease	1.17e-05	0.000281	CcSEcCtD
Eprosartan—Discomfort—Lisinopril—coronary artery disease	1.16e-05	0.000279	CcSEcCtD
Eprosartan—Hypotension—Ramipril—coronary artery disease	1.16e-05	0.000279	CcSEcCtD
Eprosartan—Anorexia—Timolol—coronary artery disease	1.16e-05	0.000278	CcSEcCtD
Eprosartan—Pruritus—Telmisartan—coronary artery disease	1.16e-05	0.000278	CcSEcCtD
Eprosartan—Nausea—Eplerenone—coronary artery disease	1.16e-05	0.000278	CcSEcCtD
Eprosartan—Dizziness—Niacin—coronary artery disease	1.15e-05	0.000277	CcSEcCtD
Eprosartan—Urticaria—Losartan—coronary artery disease	1.15e-05	0.000276	CcSEcCtD
Eprosartan—Dry mouth—Lisinopril—coronary artery disease	1.15e-05	0.000276	CcSEcCtD
Eprosartan—Body temperature increased—Losartan—coronary artery disease	1.15e-05	0.000275	CcSEcCtD
Eprosartan—Abdominal pain—Losartan—coronary artery disease	1.15e-05	0.000275	CcSEcCtD
Eprosartan—Asthenia—Captopril—coronary artery disease	1.14e-05	0.000274	CcSEcCtD
Eprosartan—Diarrhoea—Trandolapril—coronary artery disease	1.14e-05	0.000274	CcSEcCtD
Eprosartan—Vomiting—Valsartan—coronary artery disease	1.14e-05	0.000274	CcSEcCtD
Eprosartan—Diarrhoea—Enalapril—coronary artery disease	1.14e-05	0.000273	CcSEcCtD
Eprosartan—Hypotension—Timolol—coronary artery disease	1.14e-05	0.000273	CcSEcCtD
Eprosartan—Dizziness—Pravastatin—coronary artery disease	1.13e-05	0.000272	CcSEcCtD
Eprosartan—Vomiting—Olmesartan—coronary artery disease	1.13e-05	0.000272	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Ramipril—coronary artery disease	1.13e-05	0.000272	CcSEcCtD
Eprosartan—Rash—Valsartan—coronary artery disease	1.13e-05	0.000271	CcSEcCtD
Eprosartan—Dermatitis—Valsartan—coronary artery disease	1.13e-05	0.000271	CcSEcCtD
Eprosartan—Nausea—Simvastatin—coronary artery disease	1.13e-05	0.000271	CcSEcCtD
Eprosartan—Pruritus—Captopril—coronary artery disease	1.13e-05	0.00027	CcSEcCtD
Eprosartan—Rash—Olmesartan—coronary artery disease	1.12e-05	0.00027	CcSEcCtD
Eprosartan—Insomnia—Ramipril—coronary artery disease	1.12e-05	0.00027	CcSEcCtD
Eprosartan—Dermatitis—Olmesartan—coronary artery disease	1.12e-05	0.00027	CcSEcCtD
Eprosartan—Headache—Valsartan—coronary artery disease	1.12e-05	0.00027	CcSEcCtD
Eprosartan—Diarrhoea—Telmisartan—coronary artery disease	1.12e-05	0.000269	CcSEcCtD
Eprosartan—Headache—Olmesartan—coronary artery disease	1.12e-05	0.000268	CcSEcCtD
Eprosartan—Paraesthesia—Ramipril—coronary artery disease	1.12e-05	0.000268	CcSEcCtD
Eprosartan—Shock—Lisinopril—coronary artery disease	1.11e-05	0.000266	CcSEcCtD
Eprosartan—Asthenia—Perindopril—coronary artery disease	1.11e-05	0.000266	CcSEcCtD
Eprosartan—Dyspnoea—Ramipril—coronary artery disease	1.11e-05	0.000266	CcSEcCtD
Eprosartan—Vomiting—Niacin—coronary artery disease	1.11e-05	0.000266	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Timolol—coronary artery disease	1.11e-05	0.000266	CcSEcCtD
Eprosartan—Hypersensitivity—Furosemide—coronary artery disease	1.11e-05	0.000266	CcSEcCtD
Eprosartan—Somnolence—Ramipril—coronary artery disease	1.1e-05	0.000265	CcSEcCtD
Eprosartan—Thrombocytopenia—Lisinopril—coronary artery disease	1.1e-05	0.000265	CcSEcCtD
Eprosartan—Dizziness—Trandolapril—coronary artery disease	1.1e-05	0.000264	CcSEcCtD
Eprosartan—Tachycardia—Lisinopril—coronary artery disease	1.1e-05	0.000264	CcSEcCtD
Eprosartan—Insomnia—Timolol—coronary artery disease	1.1e-05	0.000264	CcSEcCtD
Eprosartan—Rash—Niacin—coronary artery disease	1.1e-05	0.000264	CcSEcCtD
Eprosartan—Dermatitis—Niacin—coronary artery disease	1.1e-05	0.000264	CcSEcCtD
Eprosartan—Dizziness—Enalapril—coronary artery disease	1.1e-05	0.000263	CcSEcCtD
Eprosartan—Dyspepsia—Ramipril—coronary artery disease	1.09e-05	0.000263	CcSEcCtD
Eprosartan—Pruritus—Perindopril—coronary artery disease	1.09e-05	0.000262	CcSEcCtD
Eprosartan—Headache—Niacin—coronary artery disease	1.09e-05	0.000262	CcSEcCtD
Eprosartan—Paraesthesia—Timolol—coronary artery disease	1.09e-05	0.000262	CcSEcCtD
Eprosartan—Vomiting—Pravastatin—coronary artery disease	1.09e-05	0.000262	CcSEcCtD
Eprosartan—Hyperhidrosis—Lisinopril—coronary artery disease	1.09e-05	0.000262	CcSEcCtD
Eprosartan—Diarrhoea—Captopril—coronary artery disease	1.09e-05	0.000261	CcSEcCtD
Eprosartan—Dyspnoea—Timolol—coronary artery disease	1.08e-05	0.00026	CcSEcCtD
Eprosartan—Dizziness—Telmisartan—coronary artery disease	1.08e-05	0.00026	CcSEcCtD
Eprosartan—Rash—Pravastatin—coronary artery disease	1.08e-05	0.00026	CcSEcCtD
Eprosartan—Dermatitis—Pravastatin—coronary artery disease	1.08e-05	0.000259	CcSEcCtD
Eprosartan—Decreased appetite—Ramipril—coronary artery disease	1.08e-05	0.000259	CcSEcCtD
Eprosartan—Somnolence—Timolol—coronary artery disease	1.08e-05	0.000259	CcSEcCtD
Eprosartan—Asthenia—Furosemide—coronary artery disease	1.08e-05	0.000259	CcSEcCtD
Eprosartan—Headache—Pravastatin—coronary artery disease	1.07e-05	0.000258	CcSEcCtD
Eprosartan—Anorexia—Lisinopril—coronary artery disease	1.07e-05	0.000258	CcSEcCtD
Eprosartan—Fatigue—Ramipril—coronary artery disease	1.07e-05	0.000257	CcSEcCtD
Eprosartan—Dyspepsia—Timolol—coronary artery disease	1.07e-05	0.000257	CcSEcCtD
Eprosartan—Hypersensitivity—Losartan—coronary artery disease	1.07e-05	0.000256	CcSEcCtD
Eprosartan—Nausea—Valsartan—coronary artery disease	1.06e-05	0.000256	CcSEcCtD
Eprosartan—Pruritus—Furosemide—coronary artery disease	1.06e-05	0.000255	CcSEcCtD
Eprosartan—Constipation—Ramipril—coronary artery disease	1.06e-05	0.000255	CcSEcCtD
Eprosartan—Nausea—Olmesartan—coronary artery disease	1.06e-05	0.000254	CcSEcCtD
Eprosartan—Vomiting—Trandolapril—coronary artery disease	1.06e-05	0.000254	CcSEcCtD
Eprosartan—Diarrhoea—Perindopril—coronary artery disease	1.06e-05	0.000254	CcSEcCtD
Eprosartan—Decreased appetite—Timolol—coronary artery disease	1.06e-05	0.000254	CcSEcCtD
Eprosartan—Vomiting—Enalapril—coronary artery disease	1.06e-05	0.000253	CcSEcCtD
Eprosartan—Hypotension—Lisinopril—coronary artery disease	1.05e-05	0.000253	CcSEcCtD
Eprosartan—Dizziness—Captopril—coronary artery disease	1.05e-05	0.000253	CcSEcCtD
Eprosartan—Rash—Trandolapril—coronary artery disease	1.05e-05	0.000252	CcSEcCtD
Eprosartan—Dermatitis—Trandolapril—coronary artery disease	1.05e-05	0.000252	CcSEcCtD
Eprosartan—Fatigue—Timolol—coronary artery disease	1.05e-05	0.000251	CcSEcCtD
Eprosartan—Rash—Enalapril—coronary artery disease	1.05e-05	0.000251	CcSEcCtD
Eprosartan—Dermatitis—Enalapril—coronary artery disease	1.05e-05	0.000251	CcSEcCtD
Eprosartan—Headache—Trandolapril—coronary artery disease	1.04e-05	0.000251	CcSEcCtD
Eprosartan—Vomiting—Telmisartan—coronary artery disease	1.04e-05	0.00025	CcSEcCtD
Eprosartan—Asthenia—Losartan—coronary artery disease	1.04e-05	0.00025	CcSEcCtD
Eprosartan—Headache—Enalapril—coronary artery disease	1.04e-05	0.00025	CcSEcCtD
Eprosartan—Pain—Timolol—coronary artery disease	1.04e-05	0.000249	CcSEcCtD
Eprosartan—Nausea—Niacin—coronary artery disease	1.03e-05	0.000248	CcSEcCtD
Eprosartan—Rash—Telmisartan—coronary artery disease	1.03e-05	0.000248	CcSEcCtD
Eprosartan—Dermatitis—Telmisartan—coronary artery disease	1.03e-05	0.000248	CcSEcCtD
Eprosartan—Diarrhoea—Furosemide—coronary artery disease	1.03e-05	0.000247	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Lisinopril—coronary artery disease	1.03e-05	0.000247	CcSEcCtD
Eprosartan—Pruritus—Losartan—coronary artery disease	1.03e-05	0.000246	CcSEcCtD
Eprosartan—Headache—Telmisartan—coronary artery disease	1.03e-05	0.000246	CcSEcCtD
Eprosartan—Feeling abnormal—Ramipril—coronary artery disease	1.02e-05	0.000246	CcSEcCtD
Eprosartan—Dizziness—Perindopril—coronary artery disease	1.02e-05	0.000245	CcSEcCtD
Eprosartan—Insomnia—Lisinopril—coronary artery disease	1.02e-05	0.000245	CcSEcCtD
Eprosartan—Nausea—Pravastatin—coronary artery disease	1.02e-05	0.000245	CcSEcCtD
Eprosartan—Gastrointestinal pain—Ramipril—coronary artery disease	1.02e-05	0.000244	CcSEcCtD
Eprosartan—Paraesthesia—Lisinopril—coronary artery disease	1.01e-05	0.000243	CcSEcCtD
Eprosartan—Vomiting—Captopril—coronary artery disease	1.01e-05	0.000243	CcSEcCtD
Eprosartan—Dyspnoea—Lisinopril—coronary artery disease	1e-05	0.000241	CcSEcCtD
Eprosartan—Rash—Captopril—coronary artery disease	1e-05	0.000241	CcSEcCtD
Eprosartan—Dermatitis—Captopril—coronary artery disease	1e-05	0.000241	CcSEcCtD
Eprosartan—Somnolence—Lisinopril—coronary artery disease	1e-05	0.000241	CcSEcCtD
Eprosartan—Feeling abnormal—Timolol—coronary artery disease	1e-05	0.00024	CcSEcCtD
Eprosartan—Headache—Captopril—coronary artery disease	9.97e-06	0.000239	CcSEcCtD
Eprosartan—Gastrointestinal pain—Timolol—coronary artery disease	9.93e-06	0.000239	CcSEcCtD
Eprosartan—Dizziness—Furosemide—coronary artery disease	9.93e-06	0.000238	CcSEcCtD
Eprosartan—Dyspepsia—Lisinopril—coronary artery disease	9.92e-06	0.000238	CcSEcCtD
Eprosartan—Diarrhoea—Losartan—coronary artery disease	9.92e-06	0.000238	CcSEcCtD
Eprosartan—Nausea—Trandolapril—coronary artery disease	9.9e-06	0.000238	CcSEcCtD
Eprosartan—Urticaria—Ramipril—coronary artery disease	9.87e-06	0.000237	CcSEcCtD
Eprosartan—Nausea—Enalapril—coronary artery disease	9.86e-06	0.000237	CcSEcCtD
Eprosartan—Vomiting—Perindopril—coronary artery disease	9.82e-06	0.000236	CcSEcCtD
Eprosartan—Abdominal pain—Ramipril—coronary artery disease	9.82e-06	0.000236	CcSEcCtD
Eprosartan—Body temperature increased—Ramipril—coronary artery disease	9.82e-06	0.000236	CcSEcCtD
Eprosartan—Decreased appetite—Lisinopril—coronary artery disease	9.8e-06	0.000235	CcSEcCtD
Eprosartan—Rash—Perindopril—coronary artery disease	9.74e-06	0.000234	CcSEcCtD
Eprosartan—Dermatitis—Perindopril—coronary artery disease	9.73e-06	0.000234	CcSEcCtD
Eprosartan—Nausea—Telmisartan—coronary artery disease	9.72e-06	0.000233	CcSEcCtD
Eprosartan—Fatigue—Lisinopril—coronary artery disease	9.72e-06	0.000233	CcSEcCtD
Eprosartan—Headache—Perindopril—coronary artery disease	9.68e-06	0.000232	CcSEcCtD
Eprosartan—Urticaria—Timolol—coronary artery disease	9.65e-06	0.000232	CcSEcCtD
Eprosartan—Constipation—Lisinopril—coronary artery disease	9.64e-06	0.000231	CcSEcCtD
Eprosartan—Pain—Lisinopril—coronary artery disease	9.64e-06	0.000231	CcSEcCtD
Eprosartan—Abdominal pain—Timolol—coronary artery disease	9.6e-06	0.000231	CcSEcCtD
Eprosartan—Body temperature increased—Timolol—coronary artery disease	9.6e-06	0.000231	CcSEcCtD
Eprosartan—Dizziness—Losartan—coronary artery disease	9.58e-06	0.00023	CcSEcCtD
Eprosartan—Vomiting—Furosemide—coronary artery disease	9.55e-06	0.000229	CcSEcCtD
Eprosartan—Rash—Furosemide—coronary artery disease	9.47e-06	0.000227	CcSEcCtD
Eprosartan—Dermatitis—Furosemide—coronary artery disease	9.46e-06	0.000227	CcSEcCtD
Eprosartan—Nausea—Captopril—coronary artery disease	9.45e-06	0.000227	CcSEcCtD
Eprosartan—Headache—Furosemide—coronary artery disease	9.41e-06	0.000226	CcSEcCtD
Eprosartan—Feeling abnormal—Lisinopril—coronary artery disease	9.29e-06	0.000223	CcSEcCtD
Eprosartan—Gastrointestinal pain—Lisinopril—coronary artery disease	9.22e-06	0.000221	CcSEcCtD
Eprosartan—Vomiting—Losartan—coronary artery disease	9.22e-06	0.000221	CcSEcCtD
Eprosartan—Nausea—Perindopril—coronary artery disease	9.18e-06	0.00022	CcSEcCtD
Eprosartan—Hypersensitivity—Ramipril—coronary artery disease	9.16e-06	0.00022	CcSEcCtD
Eprosartan—Rash—Losartan—coronary artery disease	9.14e-06	0.000219	CcSEcCtD
Eprosartan—Dermatitis—Losartan—coronary artery disease	9.13e-06	0.000219	CcSEcCtD
Eprosartan—Headache—Losartan—coronary artery disease	9.08e-06	0.000218	CcSEcCtD
Eprosartan—Urticaria—Lisinopril—coronary artery disease	8.95e-06	0.000215	CcSEcCtD
Eprosartan—Hypersensitivity—Timolol—coronary artery disease	8.95e-06	0.000215	CcSEcCtD
Eprosartan—Nausea—Furosemide—coronary artery disease	8.92e-06	0.000214	CcSEcCtD
Eprosartan—Asthenia—Ramipril—coronary artery disease	8.92e-06	0.000214	CcSEcCtD
Eprosartan—Abdominal pain—Lisinopril—coronary artery disease	8.91e-06	0.000214	CcSEcCtD
Eprosartan—Body temperature increased—Lisinopril—coronary artery disease	8.91e-06	0.000214	CcSEcCtD
Eprosartan—Pruritus—Ramipril—coronary artery disease	8.79e-06	0.000211	CcSEcCtD
Eprosartan—Asthenia—Timolol—coronary artery disease	8.72e-06	0.000209	CcSEcCtD
Eprosartan—Nausea—Losartan—coronary artery disease	8.61e-06	0.000207	CcSEcCtD
Eprosartan—Pruritus—Timolol—coronary artery disease	8.6e-06	0.000206	CcSEcCtD
Eprosartan—Diarrhoea—Ramipril—coronary artery disease	8.5e-06	0.000204	CcSEcCtD
Eprosartan—Diarrhoea—Timolol—coronary artery disease	8.31e-06	0.0002	CcSEcCtD
Eprosartan—Hypersensitivity—Lisinopril—coronary artery disease	8.3e-06	0.000199	CcSEcCtD
Eprosartan—Dizziness—Ramipril—coronary artery disease	8.22e-06	0.000197	CcSEcCtD
Eprosartan—Asthenia—Lisinopril—coronary artery disease	8.09e-06	0.000194	CcSEcCtD
Eprosartan—Dizziness—Timolol—coronary artery disease	8.03e-06	0.000193	CcSEcCtD
Eprosartan—Pruritus—Lisinopril—coronary artery disease	7.97e-06	0.000191	CcSEcCtD
Eprosartan—Vomiting—Ramipril—coronary artery disease	7.9e-06	0.00019	CcSEcCtD
Eprosartan—Rash—Ramipril—coronary artery disease	7.84e-06	0.000188	CcSEcCtD
Eprosartan—Dermatitis—Ramipril—coronary artery disease	7.83e-06	0.000188	CcSEcCtD
Eprosartan—Headache—Ramipril—coronary artery disease	7.79e-06	0.000187	CcSEcCtD
Eprosartan—Vomiting—Timolol—coronary artery disease	7.72e-06	0.000185	CcSEcCtD
Eprosartan—Diarrhoea—Lisinopril—coronary artery disease	7.71e-06	0.000185	CcSEcCtD
Eprosartan—Rash—Timolol—coronary artery disease	7.66e-06	0.000184	CcSEcCtD
Eprosartan—Dermatitis—Timolol—coronary artery disease	7.65e-06	0.000184	CcSEcCtD
Eprosartan—Headache—Timolol—coronary artery disease	7.61e-06	0.000183	CcSEcCtD
Eprosartan—Dizziness—Lisinopril—coronary artery disease	7.45e-06	0.000179	CcSEcCtD
Eprosartan—Nausea—Ramipril—coronary artery disease	7.38e-06	0.000177	CcSEcCtD
Eprosartan—Nausea—Timolol—coronary artery disease	7.22e-06	0.000173	CcSEcCtD
Eprosartan—Vomiting—Lisinopril—coronary artery disease	7.17e-06	0.000172	CcSEcCtD
Eprosartan—Rash—Lisinopril—coronary artery disease	7.11e-06	0.000171	CcSEcCtD
Eprosartan—Dermatitis—Lisinopril—coronary artery disease	7.1e-06	0.00017	CcSEcCtD
Eprosartan—Headache—Lisinopril—coronary artery disease	7.06e-06	0.00017	CcSEcCtD
Eprosartan—Nausea—Lisinopril—coronary artery disease	6.69e-06	0.000161	CcSEcCtD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—HADH—coronary artery disease	4.93e-06	0.000325	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ARNTL—coronary artery disease	4.93e-06	0.000325	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—C3—coronary artery disease	4.93e-06	0.000325	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—APOB—coronary artery disease	4.9e-06	0.000323	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CRK—coronary artery disease	4.87e-06	0.000322	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ATP2A2—coronary artery disease	4.81e-06	0.000318	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SH2B3—coronary artery disease	4.81e-06	0.000318	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VWF—coronary artery disease	4.81e-06	0.000318	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOC3—coronary artery disease	4.78e-06	0.000316	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LDLR—coronary artery disease	4.75e-06	0.000314	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AGT—coronary artery disease	4.68e-06	0.000309	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—coronary artery disease	4.67e-06	0.000309	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX2—coronary artery disease	4.67e-06	0.000309	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—coronary artery disease	4.67e-06	0.000309	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PPP2CA—coronary artery disease	4.66e-06	0.000308	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL2—coronary artery disease	4.64e-06	0.000306	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL3—coronary artery disease	4.64e-06	0.000306	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—coronary artery disease	4.62e-06	0.000305	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—coronary artery disease	4.62e-06	0.000305	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—F2R—coronary artery disease	4.59e-06	0.000303	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SDC1—coronary artery disease	4.59e-06	0.000303	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PRKCD—coronary artery disease	4.58e-06	0.000302	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—HADHA—coronary artery disease	4.56e-06	0.000301	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGB—coronary artery disease	4.49e-06	0.000296	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—HTR2A—coronary artery disease	4.48e-06	0.000296	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—C3—coronary artery disease	4.47e-06	0.000295	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPA—coronary artery disease	4.46e-06	0.000294	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDNRB—coronary artery disease	4.44e-06	0.000293	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—THBS1—coronary artery disease	4.38e-06	0.000289	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPAP2B—coronary artery disease	4.37e-06	0.000289	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CKM—coronary artery disease	4.37e-06	0.000289	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UQCRFS1—coronary artery disease	4.37e-06	0.000289	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PSMB5—coronary artery disease	4.34e-06	0.000286	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PSMA6—coronary artery disease	4.34e-06	0.000286	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—F2—coronary artery disease	4.33e-06	0.000286	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—coronary artery disease	4.27e-06	0.000282	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AGT—coronary artery disease	4.25e-06	0.000281	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDNRA—coronary artery disease	4.2e-06	0.000277	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—coronary artery disease	4.19e-06	0.000277	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CYBA—coronary artery disease	4.18e-06	0.000276	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRB1—coronary artery disease	4.18e-06	0.000276	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—DUSP6—coronary artery disease	4.16e-06	0.000275	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—coronary artery disease	4.11e-06	0.000272	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLAT—coronary artery disease	4.09e-06	0.00027	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CKMT2—coronary artery disease	4.07e-06	0.000268	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDH6A1—coronary artery disease	4.07e-06	0.000268	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SULT4A1—coronary artery disease	4.07e-06	0.000268	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PDK4—coronary artery disease	4.07e-06	0.000268	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PYGM—coronary artery disease	4.07e-06	0.000268	CbGpPWpGaD
Eprosartan—CYP2C9—Biological oxidations—POMC—coronary artery disease	4.05e-06	0.000268	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—BDKRB2—coronary artery disease	3.95e-06	0.000261	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL12—coronary artery disease	3.95e-06	0.000261	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—POMC—coronary artery disease	3.94e-06	0.00026	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—F2—coronary artery disease	3.93e-06	0.000259	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6ST—coronary artery disease	3.91e-06	0.000258	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—APOA1—coronary artery disease	3.88e-06	0.000256	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—JUNB—coronary artery disease	3.87e-06	0.000256	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLCB1—coronary artery disease	3.86e-06	0.000255	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR7—coronary artery disease	3.78e-06	0.000249	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GK—coronary artery disease	3.62e-06	0.000239	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMGCS2—coronary artery disease	3.62e-06	0.000239	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PFKM—coronary artery disease	3.62e-06	0.000239	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GYG1—coronary artery disease	3.62e-06	0.000239	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LDHA—coronary artery disease	3.62e-06	0.000239	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GATM—coronary artery disease	3.62e-06	0.000239	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ITGAV—coronary artery disease	3.6e-06	0.000238	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KNG1—coronary artery disease	3.59e-06	0.000237	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—POMC—coronary artery disease	3.58e-06	0.000236	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CREB1—coronary artery disease	3.58e-06	0.000236	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—coronary artery disease	3.54e-06	0.000234	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3C2A—coronary artery disease	3.54e-06	0.000234	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—coronary artery disease	3.54e-06	0.000234	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—coronary artery disease	3.52e-06	0.000232	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL2—coronary artery disease	3.5e-06	0.000231	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—coronary artery disease	3.5e-06	0.000231	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6R—coronary artery disease	3.49e-06	0.00023	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL10—coronary artery disease	3.49e-06	0.00023	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PLG—coronary artery disease	3.48e-06	0.00023	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AK1—coronary artery disease	3.46e-06	0.000228	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCH1—coronary artery disease	3.46e-06	0.000228	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CETP—coronary artery disease	3.42e-06	0.000226	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ADRB2—coronary artery disease	3.39e-06	0.000224	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—coronary artery disease	3.38e-06	0.000223	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKCE—coronary artery disease	3.34e-06	0.000221	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—JAK2—coronary artery disease	3.34e-06	0.00022	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SOCS1—coronary artery disease	3.33e-06	0.00022	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—S100B—coronary artery disease	3.33e-06	0.00022	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MDH2—coronary artery disease	3.31e-06	0.000219	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPAT—coronary artery disease	3.31e-06	0.000219	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—UGCG—coronary artery disease	3.31e-06	0.000219	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLCD1—coronary artery disease	3.31e-06	0.000219	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SOCS3—coronary artery disease	3.29e-06	0.000217	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KITLG—coronary artery disease	3.25e-06	0.000215	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFBR2—coronary artery disease	3.25e-06	0.000215	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PGM1—coronary artery disease	3.19e-06	0.000211	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—STAT5A—coronary artery disease	3.18e-06	0.00021	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP3—coronary artery disease	3.18e-06	0.00021	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	3.12e-06	0.000206	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	3.09e-06	0.000204	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CKB—coronary artery disease	3.08e-06	0.000203	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PYGB—coronary artery disease	3.08e-06	0.000203	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOB—coronary artery disease	3.07e-06	0.000203	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—coronary artery disease	3.07e-06	0.000203	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL8—coronary artery disease	3.05e-06	0.000201	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—JAK2—coronary artery disease	3.03e-06	0.0002	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—EDN1—coronary artery disease	3.03e-06	0.0002	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL5—coronary artery disease	3e-06	0.000198	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGF1—coronary artery disease	2.96e-06	0.000195	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CSF2—coronary artery disease	2.96e-06	0.000195	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LPL—coronary artery disease	2.94e-06	0.000194	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—RPS6KB1—coronary artery disease	2.91e-06	0.000192	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MEF2C—coronary artery disease	2.91e-06	0.000192	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—COX5B—coronary artery disease	2.9e-06	0.000191	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTM2—coronary artery disease	2.9e-06	0.000191	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PFKFB3—coronary artery disease	2.9e-06	0.000191	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DLAT—coronary artery disease	2.9e-06	0.000191	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLIN1—coronary artery disease	2.9e-06	0.000191	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ITGB3—coronary artery disease	2.84e-06	0.000187	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL8—coronary artery disease	2.77e-06	0.000183	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	2.75e-06	0.000182	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PPP2CA—coronary artery disease	2.75e-06	0.000182	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SULT1E1—coronary artery disease	2.75e-06	0.000181	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PRKCD—coronary artery disease	2.7e-06	0.000179	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	2.67e-06	0.000176	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HTR2A—coronary artery disease	2.65e-06	0.000175	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—C3—coronary artery disease	2.64e-06	0.000174	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AKR1B1—coronary artery disease	2.62e-06	0.000173	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HK2—coronary artery disease	2.62e-06	0.000173	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—HIF1A—coronary artery disease	2.52e-06	0.000166	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC27A1—coronary artery disease	2.51e-06	0.000166	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AGT—coronary artery disease	2.51e-06	0.000166	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CPT1B—coronary artery disease	2.46e-06	0.000163	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LCAT—coronary artery disease	2.46e-06	0.000163	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—LEP—coronary artery disease	2.46e-06	0.000162	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOE—coronary artery disease	2.46e-06	0.000162	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—APOA1—coronary artery disease	2.43e-06	0.000161	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOA4—coronary artery disease	2.42e-06	0.00016	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KDR—coronary artery disease	2.41e-06	0.000159	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK14—coronary artery disease	2.39e-06	0.000158	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	2.37e-06	0.000157	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ESR1—coronary artery disease	2.35e-06	0.000155	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PDHA1—coronary artery disease	2.34e-06	0.000154	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCLM—coronary artery disease	2.34e-06	0.000154	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—F2—coronary artery disease	2.32e-06	0.000153	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FN1—coronary artery disease	2.32e-06	0.000153	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6ST—coronary artery disease	2.31e-06	0.000153	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NFKBIA—coronary artery disease	2.29e-06	0.000151	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	2.26e-06	0.000149	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TXNRD1—coronary artery disease	2.26e-06	0.000149	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP11B2—coronary artery disease	2.26e-06	0.000149	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC22A3—coronary artery disease	2.23e-06	0.000147	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—KIT—coronary artery disease	2.22e-06	0.000147	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ARNTL—coronary artery disease	2.2e-06	0.000145	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HADH—coronary artery disease	2.2e-06	0.000145	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	2.16e-06	0.000143	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—GSK3B—coronary artery disease	2.13e-06	0.000141	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—POMC—coronary artery disease	2.11e-06	0.00014	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CREB1—coronary artery disease	2.11e-06	0.00014	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	2.11e-06	0.000139	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLA2G2A—coronary artery disease	2.08e-06	0.000137	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPX2—coronary artery disease	2.08e-06	0.000137	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOA2—coronary artery disease	2.08e-06	0.000137	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL2—coronary artery disease	2.07e-06	0.000137	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6R—coronary artery disease	2.06e-06	0.000136	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCG5—coronary artery disease	2.06e-06	0.000136	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HK1—coronary artery disease	2.06e-06	0.000136	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPX4—coronary artery disease	2.06e-06	0.000136	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SULT1A1—coronary artery disease	2.06e-06	0.000136	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	2.05e-06	0.000136	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IGF1—coronary artery disease	2.03e-06	0.000134	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HADHA—coronary artery disease	2.03e-06	0.000134	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—MAPK1—coronary artery disease	2.02e-06	0.000134	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTA1—coronary artery disease	2.01e-06	0.000133	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPA—coronary artery disease	1.99e-06	0.000131	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.93e-06	0.000128	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—SERPINE1—coronary artery disease	1.93e-06	0.000127	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLCB3—coronary artery disease	1.92e-06	0.000127	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOA5—coronary artery disease	1.9e-06	0.000126	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—FGF2—coronary artery disease	1.87e-06	0.000123	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—P4HB—coronary artery disease	1.87e-06	0.000123	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.85e-06	0.000122	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—NOS3—coronary artery disease	1.84e-06	0.000122	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLA2G1B—coronary artery disease	1.83e-06	0.000121	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.81e-06	0.00012	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—JAK2—coronary artery disease	1.79e-06	0.000118	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.79e-06	0.000118	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—PIK3CA—coronary artery disease	1.76e-06	0.000116	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—VCAN—coronary artery disease	1.73e-06	0.000114	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDOA—coronary artery disease	1.71e-06	0.000113	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—DCN—coronary artery disease	1.66e-06	0.00011	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL8—coronary artery disease	1.64e-06	0.000108	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALDH2—coronary artery disease	1.62e-06	0.000107	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—AKT1—coronary artery disease	1.58e-06	0.000104	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.58e-06	0.000104	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CYP2C19—coronary artery disease	1.58e-06	0.000104	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3C2A—coronary artery disease	1.58e-06	0.000104	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LIPC—coronary artery disease	1.58e-06	0.000104	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HBA1—coronary artery disease	1.58e-06	0.000104	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOC3—coronary artery disease	1.57e-06	0.000103	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CASP3—coronary artery disease	1.57e-06	0.000103	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LDLR—coronary artery disease	1.56e-06	0.000103	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.56e-06	0.000103	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—coronary artery disease	1.55e-06	0.000103	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTT1—coronary artery disease	1.54e-06	0.000102	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SLC9A1—coronary artery disease	1.54e-06	0.000102	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCND1—coronary artery disease	1.52e-06	0.000101	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CETP—coronary artery disease	1.52e-06	0.0001	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GCLC—coronary artery disease	1.52e-06	0.0001	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—SDC1—coronary artery disease	1.5e-06	9.93e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MMP9—coronary artery disease	1.48e-06	9.76e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—AKT1—coronary artery disease	1.43e-06	9.47e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PSMA6—coronary artery disease	1.42e-06	9.38e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PSMB5—coronary artery disease	1.42e-06	9.38e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	1.42e-06	9.37e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CTGF—coronary artery disease	1.39e-06	9.17e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GOT2—coronary artery disease	1.38e-06	9.09e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMGCR—coronary artery disease	1.38e-06	9.09e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—VEGFA—coronary artery disease	1.33e-06	8.77e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PLCB1—coronary artery disease	1.27e-06	8.35e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	1.24e-06	8.19e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ABCA1—coronary artery disease	1.23e-06	8.1e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—TGFB1—coronary artery disease	1.22e-06	8.05e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—MAPK1—coronary artery disease	1.2e-06	7.89e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GOT1—coronary artery disease	1.19e-06	7.84e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GGT1—coronary artery disease	1.19e-06	7.84e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTP1—coronary artery disease	1.07e-06	7.04e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARGC1A—coronary artery disease	1.06e-06	6.98e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—HMOX1—coronary artery disease	1.05e-06	6.95e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CAT—coronary artery disease	1.04e-06	6.85e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—PIK3CA—coronary artery disease	1.04e-06	6.85e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOB—coronary artery disease	1.01e-06	6.65e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GSTM1—coronary artery disease	9.81e-07	6.47e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—LPL—coronary artery disease	9.63e-07	6.35e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—GPX1—coronary artery disease	9.39e-07	6.2e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—coronary artery disease	9.19e-07	6.06e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—CD36—coronary artery disease	9.15e-07	6.04e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPP2CA—coronary artery disease	9.03e-07	5.96e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—MTHFR—coronary artery disease	8.67e-07	5.72e-05	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—AKT1—coronary artery disease	8.47e-07	5.59e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AGT—coronary artery disease	8.23e-07	5.44e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOE—coronary artery disease	8.07e-07	5.33e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—APOA1—coronary artery disease	7.98e-07	5.27e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	7.64e-07	5.04e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PPARG—coronary artery disease	7.03e-07	4.64e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—POMC—coronary artery disease	6.93e-07	4.58e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—coronary artery disease	6.32e-07	4.17e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—NOS3—coronary artery disease	6.04e-07	3.99e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PTGS2—coronary artery disease	5.53e-07	3.65e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—PIK3CA—coronary artery disease	3.4e-07	2.25e-05	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AKT1—coronary artery disease	2.78e-07	1.83e-05	CbGpPWpGaD
